Compare Bristol-Myers Squibb Co (BMY) vs VanEck Video Gaming and eSports ETF (ESPO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bristol-Myers Squibb Co vs VanEck Video Gaming and eSports ETF — how do they compare? Bristol-Myers Squibb Co trades at $58.33 (market cap $116.30B), while VanEck Video Gaming and eSports ETF trades at $91.42. The key difference: Bristol-Myers Squibb Co pays a 4.42% dividend while VanEck Video Gaming and eSports ETF pays none, and Bristol-Myers Squibb Co is trading nearer its 52-week high, VanEck Video Gaming and eSports ETF nearer its low. Which is the better fit depends on your goals.
| BMY | ESPO | |
|---|---|---|
Market Cap | $116.30B | — |
Sector | Health | Sector/Thematic |
52-Week High | $62.37 | $122.30 |
52-Week Low | $42.60 | $85.25 |
Enterprise Value | $152.24B | — |
Dividend Yield | 4.42% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bristol Myers Squibb (BMY) trades at $59.34, up 3.06% today, with a bullish technical signal and consistent earnings beats. The stock shows strong profitability with a 15.01% net margin and 38.84% ROE, though debt levels have risen. Recent FDA acceptance for mezigdomide in multiple myeloma highlights pipeline progress. Analysts are mixed with a $60 consensus target, slightly above current price.
BMY offers value with a P/E of 16.62 and a safe 4.3% dividend yield, but faces patent cliff risks and pricing pressures. Earnings growth and pipeline execution are key catalysts, while high debt and competitive threats require monitoring. The stock presents a balanced opportunity for income-focused investors with moderate risk tolerance.
ESPO, the VanEck Video Gaming and eSports ETF, trades at $91.78, down 0.62% on the day. Technical indicators show a bullish trend with moving averages signaling strength, though oscillators are neutral and short-term RSI levels suggest overbought conditions. Recent news highlights institutional accumulation and AI-driven profit potential in the gaming sector, with Assetmark Inc. increasing its stake by 35.9% as of its latest 13F filing (SEC, Q1 2026).
The outlook for ESPO is supported by structural growth in digital entertainment and AI efficiency gains, but risks include sector volatility and high valuation multiples. The ETF offers exposure to a high-growth industry, yet investors face concentration risk in gaming stocks and sensitivity to consumer discretionary spending trends.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Bristol-Myers Squibb Co
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
Read more on BMY →About VanEck Video Gaming and eSports ETF
ESPO is a thematic ETF that invests in the global video gaming and eSports industry. It provides exposure to companies involved in game development, hardware, and streaming, including major firms like Tencent, Nintendo, and Electronic Arts.
Read more on ESPO →
